Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Condition(s):Schizophrenia Spectrum DisordersLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Schizophrenia Spectrum DisordersLast Updated:March 5, 2024Recruiting
Condition(s):Motivational Interviewing; Schizophrenia Spectrum Disorder; Medication AdherenceLast Updated:March 7, 2024Completed
Condition(s):Schizophrenia Spectrum and Other Psychotic Disorders; Treatment-resistant SchizophreniaLast Updated:May 10, 2022Completed
Condition(s):Schizophrenia; SuicideLast Updated:July 11, 2023Completed
Condition(s):Schizophrenia Spectrum Disorders; Family CaregiversLast Updated:September 9, 2020Completed
Condition(s):SchizophreniaLast Updated:August 22, 2013Completed
Condition(s):SchizophreniaLast Updated:November 3, 2009Completed
Condition(s):Schizophrenia and Related Disorders; Mental CompetencyLast Updated:January 12, 2021Unknown status
Condition(s):Schizophrenia and Related Disorders; Mitochondrial Alteration; Cognitive ImpairmentLast Updated:February 20, 2024Not yet recruiting
Condition(s):Schizophrenia; Schizophreniform Disorders; Schizoaffective DisorderLast Updated:April 27, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.